Study #BMTCTN1702
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (CTRL-ALT-D)
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
The purpose of this study is to determine if a search strategy of searching for an HLA-matched unrelated donor for allogeneic transplantation if possible then an alternative donor if an HLA-matched unrelated donor is not available versus proceeding directly to an alternative donor transplant will result in better survival for allogeneic transplant recipients within 2 years after study enrollment.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Acute Myeloid Leukemia;Acute Lymphoblastic Leukemia;Myelodysplastic Syndromes;Non-hodgkin Lymphoma;Hodgkin Lymphoma;Acquired Aplastic Anemia;Sickle Cell Disease
Study phase:
Not applicable
Physician name:
Samer Srour
Department:
Stem Cell Transplantation
For general questions about clinical trials:
1-866-397-2063
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.